Core Viewpoint - The stock of Chunli Medical (688236) has shown a slight decline, with a closing price of 25.07 yuan on August 13, 2025, reflecting a decrease of 0.04% [1] Group 1: Stock Performance and Trading Data - On August 13, 2025, the stock had a turnover rate of 1.2%, with a trading volume of 34,500 hands and a transaction amount of 85.43 million yuan [1] - The net inflow of main funds was 3.79% of the total transaction amount, while retail investors experienced a net outflow of 4.99% [1] - Over the past five days, the stock price fluctuated, with a notable increase of 4.54% on August 12, 2025, and a decrease of 0.04% on August 13, 2025 [2] Group 2: Financial Metrics and Industry Comparison - Chunli Medical's total market value is 9.616 billion yuan, with a net asset of 2.879 billion yuan and a net profit of 58.0711 million yuan [3] - The company has a price-to-earnings ratio of 41.4 and a price-to-book ratio of 3.36, both of which are favorable compared to the industry averages [3] - The gross profit margin stands at 66.69%, significantly higher than the industry average of 51.34%, indicating strong profitability [3] Group 3: Institutional Ratings and Target Price - In the last 90 days, four institutions have provided ratings for the stock, with three giving a buy rating and one an increase rating [4] - The average target price set by institutions over the past 90 days is 18.0 yuan, suggesting potential upside from the current trading price [4]
股票行情快报:春立医疗(688236)8月13日主力资金净买入323.80万元